HCL Technologies launches dedicated Microsoft biz unit
The HCL Microsoft Business Unit will create intellectual property extending the Microsoft platform for customer-specific scenarios and will also provide additional support to clients in the financial services, healthcare and life sciences, manufacturing, retail, and travel industries, it added.
Centrum maintains add on HCL Technologies, target price Rs 650
Steady margin expansion along with improvement in payouts are positives for th...
E-commerce offers an unbelievable platform and technology but won't kill offline, says Aditya Burman
E-commerce & kirana can co-exist, claims...
Market Movers: Damani boost to Spencer's, RJ cuts stake in Escorts; airline stocks slip
The broader market performed better, as smallcaps ended flat.
US needs to keep its ethos of being the land of opportunity, innovation: Sanjay Mehrotra, Micron
Immigration is important, H-1B visas are important and providing an environment that can continue to attract top talent from around the world to the United States, not just for studies but also to stay and contribute to the country for innovation and creating jobs is important, Kanpur born CEO of Micron Technology, Sanjay Mehrotra said.
Jhunjhunwala, MFs, FPIs raise stake in this midcap hospital chain
Mutual funds also increased stake and now hold 4.99 per in the hospital chain.
HDFC Securities maintains buy on HCL Technologies, target price Rs 665
The brokerage maintained a buy on HCL Tech following a better than expected revenue and margin performance and about 2% increase in EPS.
Share market update: Pharma shares up; Piramal Enterprises rises 1%
The Nifty Pharma index was trading 0.2 per cent up at 8285.95 .
Masayoshi Son is no angel. He might want to give it a try
Masayoshi Son isn’t timid, to be sure. His reputation is built upon decades of courageous bets that netted him, his investors, and his founders billions of dollars. The most famous being Jack Ma and a little e-commerce company that became Alibaba Group Holding Ltd.
Clarivate buys Piramal's healthcare analytics business for $950 million
With this acquisition, the over $5 billion Clarivate is expected to be well positioned in the $19 billion Life Sciences analytics market, which is enjoying double-digit growth, to support customers across the entire drug, device and medical technology lifecycle from research to outcome.
HCL Technologies expects strong demand across sectors in coming quarters
The company, which posted 15.5 per cent rise in revenue in the December quarter, is also seeing strong growth in the European and US markets.
Telcos should run media campaigns to check pesky calls, messages: Trai
Telcos, it said, would also “need to share details with mobile users of the relevant web portal/apps created” in their upcoming media campaign on ways to rein in pesky calls and text messages.
Maybank Kim Eng Securities maintains buy on Sterlite Technologies, target price Rs 190
Though the brokerage cut its FY20-22 estimated EPS by 4-14%, the stock is trading at an attractive valuation of 8.3 times FY21 estimated earnings.
Zydus & CMS enter pact for Desidustat in Greater China
The agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease (CKD) not-on-dialysis and for the treatment of anemia CKD patients on dialysis in Greater China, Zydus said in a statement. "Under the license agreement, CMS will pay Zydus an initial upfront payment," it added.
A happy coincidence: Anand Mahindra’s tweet helps Tech Mahindra CEO reconnect with an old classmate
Twitterati couldn’t help but absolutely adore the ‘add-on’ to the sweet proposal.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service